To assess the clinical utility of GFAP and NfL in plasma, particularly in distinguishing healthy controls from patients with cognitive complaints (MCI and AD) and potentially predicting cerebral amyloid status, ROC analyses were performed and adjusted for sex and age. Here, NEFL is linked to Alzheimer disease.